Neonatal Ventilator Market Size Was Valued at USD 421.04 Million in 2023, and is Projected to Reach USD 787.18 Million by 2032, Growing at a CAGR of 7.2 % From 2024-2032.

Eye Inflammation Treatment Market Size Was Valued at USD 616.5 Million in 2023, and is Projected to Reach USD 1032.75 Million by 2032, Growing at a CAGR of 5.9% From 2024-2032.

The increasing incidence rate of diseases including chronic pain, cardiovascular diseases, and hormonal disorders will be a major growth point for transdermal drug delivery systems. Such systems bring improved drug effectiveness and dosage that are deemed beneficial by aging population of the world and patients on long-term prescriptions. Also, increased use of transdermal patches for patents such as nicotine replacement therapy as well as contraceptives also propels the market growth.

Paclitaxel Injection is a chemotherapy drug widely used for the treatment of various cancers, including breast, ovarian, and non-small cell lung cancer. It belongs to the taxane class of drugs and works by stabilizing microtubules, thereby inhibiting cell division and promoting cancer cell death. Paclitaxel is administered intravenously and is available in both conventional formulations (requiring solvents like Cremophor EL) and advanced albumin-bound formulations (such as Abraxane), which offer improved safety profiles and bioavailability.